This inventor holds 4 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1996-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1997
Title: G. Erard Schmid: Pharmaceutical Patent Inventor
Introduction
G. Erard Schmid is an inventor associated with Kienberg, Switzerland. His work includes pharmaceutical compounds described in patents concerning the inhibition of thrombin-induced platelet aggregation and fibrinogen clotting. The supplied information credits him with 4 patents.
Latest Patents
One of Schmid’s listed patent inventions concerns guanidine derivatives represented by a chemical formula whose substituents are defined in the patent description. The compounds, including their hydrates and solvates, are described as inhibiting thrombin-induced platelet aggregation and the clotting of fibrinogen in plasma. The patent describes preparing these compounds through amidination or, depending on whether a specified group is NH or O, through amide formation or esterification.
The supplied patent description appears twice in the information provided, so it is presented here once.
Career Highlights
Schmid is associated with Hoffmann-La Roche Inc., a pharmaceutical company. The available details identify his location, patent count, and work on medicinal chemistry inventions, but do not provide further information about his role or career history.
Collaborations
The supplied information names Kurt Hilpert and Jean Ackermann as Schmid’s coworkers. It does not specify particular joint patents or projects involving them.
Conclusion
G. Erard Schmid’s listed patent work reflects research into guanidine derivatives with potential effects on platelet aggregation and blood clotting.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
